— Know what they know.
Not Investment Advice

LYCA Institutional Ownership

Lycia Therapeutics Inc.
YTD: -3.8%
$26.64
-2.21 (-7.66%)
 
NASDAQ · Healthcare · Biotechnology · $1.5B mcap · 7M float · 30.83% daily turnover · Short 32% of daily vol
Credit Risk of going bust: not rated Bonds: none of note held by US funds details ▾
Not rated: no recent balance sheet.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

No institutional holdings data available for LYCA

Institutional holdings are sourced from SEC 13F filings and may not be available for all securities.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms